APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diabetic Therapeutic Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Diabetic Therapeutic Drugs Market Analysis and Forecast 2026-2032

26 December 2025209 pages

Choose your research edition.

Industry ResearchDiabetic Therapeutic Drugs Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Diabetic Therapeutic Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Diabetic Therapeutic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diabetic Therapeutic Drugs Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Diabetic Therapeutic Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Diabetic Therapeutic Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Diabetic Therapeutic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Diabetic Therapeutic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Diabetic Therapeutic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Diabetic Therapeutic Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Diabetic Therapeutic Drugs include Arbutus Biopharma, AstraZeneca, Belrose Pharma, Dong-A ST, Eisai, F. Hoffmann-La Roche, Mitsubishi Tanabe Pharma, Novo Nordisk and Perle Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Diabetic Therapeutic Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Diabetic Therapeutic Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Diabetic Therapeutic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetic Therapeutic Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Diabetic Therapeutic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Diabetic Therapeutic Drugs sales, projected growth trends, production technology, application and end-user industry.

Diabetic Therapeutic Drugs Segment by Company

Arbutus Biopharma

AstraZeneca

Belrose Pharma

Dong-A ST

Eisai

F. Hoffmann-La Roche

Mitsubishi Tanabe Pharma

Novo Nordisk

Perle Biosciences

Sun Pharma

Pfizer

Eli Lilly

Merck

Novartis

Sanofi

Takeda Pharmaceuticals

Diabetic Therapeutic Drugs Segment by Type

Insulin Therapies

Non-Insulin Therapies

Diabetic Therapeutic Drugs Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Gestational Diabetes

Diabetic Therapeutic Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Therapeutic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diabetic Therapeutic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Therapeutic Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Diabetic Therapeutic Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Diabetic Therapeutic Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Therapeutic Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Diabetic Therapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Insulin Therapies Major Manufacturers Table 3. Non-Insulin Therapies Major Manufacturers Table 4. Global Diabetic Therapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Type 1 Diabetes Major Manufacturers Table 6. Type 2 Diabetes Major Manufacturers Table 7. Gestational Diabetes Major Manufacturers Table 8. Diabetic Therapeutic Drugs Industry Trends Table 9. Diabetic Therapeutic Drugs Industry Drivers Table 10. Diabetic Therapeutic Drugs Industry Opportunities and Challenges Table 11. Diabetic Therapeutic Drugs Industry Restraints Table 12. Global Diabetic Therapeutic Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Diabetic Therapeutic Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Diabetic Therapeutic Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Diabetic Therapeutic Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Diabetic Therapeutic Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Diabetic Therapeutic Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Diabetic Therapeutic Drugs Sales by Region (2021-2026) & (Tons) Table 19. Global Diabetic Therapeutic Drugs Sales by Region (2027-2032) & (Tons) Table 20. Global Diabetic Therapeutic Drugs Sales Market Share by Region (2021-2026) Table 21. Global Diabetic Therapeutic Drugs Sales Market Share by Region (2027-2032) Table 22. Global Diabetic Therapeutic Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Diabetic Therapeutic Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Diabetic Therapeutic Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Diabetic Therapeutic Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Diabetic Therapeutic Drugs Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 27. Global Diabetic Therapeutic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Diabetic Therapeutic Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Diabetic Therapeutic Drugs Manufacturers, Product Type & Application Table 30. Global Diabetic Therapeutic Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Diabetic Therapeutic Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Diabetic Therapeutic Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Diabetic Therapeutic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Diabetic Therapeutic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Diabetic Therapeutic Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Diabetic Therapeutic Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Diabetic Therapeutic Drugs Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 39. Global Diabetic Therapeutic Drugs Sales by Type (2021-2026) & (Tons) Table 40. Global Diabetic Therapeutic Drugs Sales by Type (2027-2032) & (Tons) Table 41. Global Diabetic Therapeutic Drugs Sales Market Share by Type (2021-2026) Table 42. Global Diabetic Therapeutic Drugs Sales Market Share by Type (2027-2032) Table 43. Global Diabetic Therapeutic Drugs Price by Type (2021-2026) & (US$/Kg) Table 44. Global Diabetic Therapeutic Drugs Price by Type (2027-2032) & (US$/Kg) Table 45. Global Diabetic Therapeutic Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Diabetic Therapeutic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Diabetic Therapeutic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Diabetic Therapeutic Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Diabetic Therapeutic Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Diabetic Therapeutic Drugs Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 51. Global Diabetic Therapeutic Drugs Sales by Application (2021-2026) & (Tons) Table 52. Global Diabetic Therapeutic Drugs Sales by Application (2027-2032) & (Tons) Table 53. Global Diabetic Therapeutic Drugs Sales Market Share by Application (2021-2026) Table 54. Global Diabetic Therapeutic Drugs Sales Market Share by Application (2027-2032) Table 55. Global Diabetic Therapeutic Drugs Price by Application (2021-2026) & (US$/Kg) Table 56. Global Diabetic Therapeutic Drugs Price by Application (2027-2032) & (US$/Kg) Table 57. Arbutus Biopharma Company Information Table 58. Arbutus Biopharma Business Overview Table 59. Arbutus Biopharma Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. Arbutus Biopharma Diabetic Therapeutic Drugs Product Portfolio Table 61. Arbutus Biopharma Recent Development Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 65. AstraZeneca Diabetic Therapeutic Drugs Product Portfolio Table 66. AstraZeneca Recent Development Table 67. Belrose Pharma Company Information Table 68. Belrose Pharma Business Overview Table 69. Belrose Pharma Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. Belrose Pharma Diabetic Therapeutic Drugs Product Portfolio Table 71. Belrose Pharma Recent Development Table 72. Dong-A ST Company Information Table 73. Dong-A ST Business Overview Table 74. Dong-A ST Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 75. Dong-A ST Diabetic Therapeutic Drugs Product Portfolio Table 76. Dong-A ST Recent Development Table 77. Eisai Company Information Table 78. Eisai Business Overview Table 79. Eisai Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 80. Eisai Diabetic Therapeutic Drugs Product Portfolio Table 81. Eisai Recent Development Table 82. F. Hoffmann-La Roche Company Information Table 83. F. Hoffmann-La Roche Business Overview Table 84. F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 85. F. Hoffmann-La Roche Diabetic Therapeutic Drugs Product Portfolio Table 86. F. Hoffmann-La Roche Recent Development Table 87. Mitsubishi Tanabe Pharma Company Information Table 88. Mitsubishi Tanabe Pharma Business Overview Table 89. Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 90. Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Product Portfolio Table 91. Mitsubishi Tanabe Pharma Recent Development Table 92. Novo Nordisk Company Information Table 93. Novo Nordisk Business Overview Table 94. Novo Nordisk Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 95. Novo Nordisk Diabetic Therapeutic Drugs Product Portfolio Table 96. Novo Nordisk Recent Development Table 97. Perle Biosciences Company Information Table 98. Perle Biosciences Business Overview Table 99. Perle Biosciences Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 100. Perle Biosciences Diabetic Therapeutic Drugs Product Portfolio Table 101. Perle Biosciences Recent Development Table 102. Sun Pharma Company Information Table 103. Sun Pharma Business Overview Table 104. Sun Pharma Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 105. Sun Pharma Diabetic Therapeutic Drugs Product Portfolio Table 106. Sun Pharma Recent Development Table 107. Pfizer Company Information Table 108. Pfizer Business Overview Table 109. Pfizer Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 110. Pfizer Diabetic Therapeutic Drugs Product Portfolio Table 111. Pfizer Recent Development Table 112. Eli Lilly Company Information Table 113. Eli Lilly Business Overview Table 114. Eli Lilly Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 115. Eli Lilly Diabetic Therapeutic Drugs Product Portfolio Table 116. Eli Lilly Recent Development Table 117. Merck Company Information Table 118. Merck Business Overview Table 119. Merck Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 120. Merck Diabetic Therapeutic Drugs Product Portfolio Table 121. Merck Recent Development Table 122. Novartis Company Information Table 123. Novartis Business Overview Table 124. Novartis Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 125. Novartis Diabetic Therapeutic Drugs Product Portfolio Table 126. Novartis Recent Development Table 127. Sanofi Company Information Table 128. Sanofi Business Overview Table 129. Sanofi Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 130. Sanofi Diabetic Therapeutic Drugs Product Portfolio Table 131. Sanofi Recent Development Table 132. Takeda Pharmaceuticals Company Information Table 133. Takeda Pharmaceuticals Business Overview Table 134. Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 135. Takeda Pharmaceuticals Diabetic Therapeutic Drugs Product Portfolio Table 136. Takeda Pharmaceuticals Recent Development Table 137. North America Diabetic Therapeutic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 138. North America Diabetic Therapeutic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 139. North America Diabetic Therapeutic Drugs Sales by Type (2021-2026) & (Tons) Table 140. North America Diabetic Therapeutic Drugs Sales by Type (2027-2032) & (Tons) Table 141. North America Diabetic Therapeutic Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 142. North America Diabetic Therapeutic Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 143. North America Diabetic Therapeutic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 144. North America Diabetic Therapeutic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 145. North America Diabetic Therapeutic Drugs Sales by Application (2021-2026) & (Tons) Table 146. North America Diabetic Therapeutic Drugs Sales by Application (2027-2032) & (Tons) Table 147. North America Diabetic Therapeutic Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 148. North America Diabetic Therapeutic Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 149. North America Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. North America Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. North America Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. North America Diabetic Therapeutic Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 153. North America Diabetic Therapeutic Drugs Sales by Country (2021-2026) & (Tons) Table 154. North America Diabetic Therapeutic Drugs Sales by Country (2027-2032) & (Tons) Table 155. North America Diabetic Therapeutic Drugs Sales Price by Country (2021-2026) & (US$/Kg) Table 156. North America Diabetic Therapeutic Drugs Sales Price by Country (2027-2032) & (US$/Kg) Table 157. United States Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 158. Canada Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 159. Mexico Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 160. Europe Diabetic Therapeutic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 161. Europe Diabetic Therapeutic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 162. Europe Diabetic Therapeutic Drugs Sales by Type (2021-2026) & (Tons) Table 163. Europe Diabetic Therapeutic Drugs Sales by Type (2027-2032) & (Tons) Table 164. Europe Diabetic Therapeutic Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 165. Europe Diabetic Therapeutic Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 166. Europe Diabetic Therapeutic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 167. Europe Diabetic Therapeutic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 168. Europe Diabetic Therapeutic Drugs Sales by Application (2021-2026) & (Tons) Table 169. Europe Diabetic Therapeutic Drugs Sales by Application (2027-2032) & (Tons) Table 170. Europe Diabetic Therapeutic Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 171. Europe Diabetic Therapeutic Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 172. Europe Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Europe Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Europe Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Europe Diabetic Therapeutic Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 176. Europe Diabetic Therapeutic Drugs Sales by Country (2021-2026) & (Tons) Table 177. Europe Diabetic Therapeutic Drugs Sales by Country (2027-2032) & (Tons) Table 178. Europe Diabetic Therapeutic Drugs Sales Price by Country (2021-2026) & (US$/Kg) Table 179. Europe Diabetic Therapeutic Drugs Sales Price by Country (2027-2032) & (US$/Kg) Table 180. Germany Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 181. France Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 182. U.K. Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 183. Italy Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 184. Russia Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 185. Spain Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 186. Netherlands Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 187. Switzerland Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 188. Sweden Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 189. Poland Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 190. China Diabetic Therapeutic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 191. China Diabetic Therapeutic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 192. China Diabetic Therapeutic Drugs Sales by Type (2021-2026) & (Tons) Table 193. China Diabetic Therapeutic Drugs Sales by Type (2027-2032) & (Tons) Table 194. China Diabetic Therapeutic Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 195. China Diabetic Therapeutic Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 196. China Diabetic Therapeutic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 197. China Diabetic Therapeutic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 198. China Diabetic Therapeutic Drugs Sales by Application (2021-2026) & (Tons) Table 199. China Diabetic Therapeutic Drugs Sales by Application (2027-2032) & (Tons) Table 200. China Diabetic Therapeutic Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 201. China Diabetic Therapeutic Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 202. Asia Diabetic Therapeutic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 203. Asia Diabetic Therapeutic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 204. Asia Diabetic Therapeutic Drugs Sales by Type (2021-2026) & (Tons) Table 205. Asia Diabetic Therapeutic Drugs Sales by Type (2027-2032) & (Tons) Table 206. Asia Diabetic Therapeutic Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 207. Asia Diabetic Therapeutic Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 208. Asia Diabetic Therapeutic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 209. Asia Diabetic Therapeutic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 210. Asia Diabetic Therapeutic Drugs Sales by Application (2021-2026) & (Tons) Table 211. Asia Diabetic Therapeutic Drugs Sales by Application (2027-2032) & (Tons) Table 212. Asia Diabetic Therapeutic Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 213. Asia Diabetic Therapeutic Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 214. Asia Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 215. Asia Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 216. Asia Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 217. Asia Diabetic Therapeutic Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 218. Asia Diabetic Therapeutic Drugs Sales by Country (2021-2026) & (Tons) Table 219. Asia Diabetic Therapeutic Drugs Sales by Country (2027-2032) & (Tons) Table 220. Asia Diabetic Therapeutic Drugs Sales Price by Country (2021-2026) & (US$/Kg) Table 221. Asia Diabetic Therapeutic Drugs Sales Price by Country (2027-2032) & (US$/Kg) Table 222. Japan Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 223. South Korea Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 224. India Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 225. Australia Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 226. Taiwan Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 227. Southeast Asia Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 228. SAMEA Diabetic Therapeutic Drugs Revenue by Type (2021-2026) & (US$ Million) Table 229. SAMEA Diabetic Therapeutic Drugs Revenue by Type (2027-2032) & (US$ Million) Table 230. SAMEA Diabetic Therapeutic Drugs Sales by Type (2021-2026) & (Tons) Table 231. SAMEA Diabetic Therapeutic Drugs Sales by Type (2027-2032) & (Tons) Table 232. SAMEA Diabetic Therapeutic Drugs Sales Price by Type (2021-2026) & (US$/Kg) Table 233. SAMEA Diabetic Therapeutic Drugs Sales Price by Type (2027-2032) & (US$/Kg) Table 234. SAMEA Diabetic Therapeutic Drugs Revenue by Application (2021-2026) & (US$ Million) Table 235. SAMEA Diabetic Therapeutic Drugs Revenue by Application (2027-2032) & (US$ Million) Table 236. SAMEA Diabetic Therapeutic Drugs Sales by Application (2021-2026) & (Tons) Table 237. SAMEA Diabetic Therapeutic Drugs Sales by Application (2027-2032) & (Tons) Table 238. SAMEA Diabetic Therapeutic Drugs Sales Price by Application (2021-2026) & (US$/Kg) Table 239. SAMEA Diabetic Therapeutic Drugs Sales Price by Application (2027-2032) & (US$/Kg) Table 240. SAMEA Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. SAMEA Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. SAMEA Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. SAMEA Diabetic Therapeutic Drugs Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 244. SAMEA Diabetic Therapeutic Drugs Sales by Country (2021-2026) & (Tons) Table 245. SAMEA Diabetic Therapeutic Drugs Sales by Country (2027-2032) & (Tons) Table 246. SAMEA Diabetic Therapeutic Drugs Sales Price by Country (2021-2026) & (US$/Kg) Table 247. SAMEA Diabetic Therapeutic Drugs Sales Price by Country (2027-2032) & (US$/Kg) Table 248. Brazil Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 249. Argentina Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 250. Chile Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 251. Colombia Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 252. Peru Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 253. Saudi Arabia Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 254. Israel Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 255. UAE Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 256. Turkey Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 257. Iran Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 258. Egypt Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Table 259. Key Raw Materials Table 260. Raw Materials Key Suppliers Table 261. Diabetic Therapeutic Drugs Distributors List Table 262. Diabetic Therapeutic Drugs Customers List Table 263. Research Programs/Design for This Report Table 264. Authors List of This Report Table 265. Secondary Sources Table 266. Primary Sources List of Figures Figure 1. Diabetic Therapeutic Drugs Image Figure 2. Global Diabetic Therapeutic Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diabetic Therapeutic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Insulin Therapies Image Figure 5. Non-Insulin Therapies Image Figure 6. Global Diabetic Therapeutic Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Diabetic Therapeutic Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Type 1 Diabetes Image Figure 9. Type 2 Diabetes Image Figure 10. Gestational Diabetes Image Figure 11. Global Diabetic Therapeutic Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Diabetic Therapeutic Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Diabetic Therapeutic Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Diabetic Therapeutic Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Diabetic Therapeutic Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Diabetic Therapeutic Drugs Sales (2021-2032) & (Tons) Figure 17. Global Diabetic Therapeutic Drugs Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 18. Global Diabetic Therapeutic Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Diabetic Therapeutic Drugs Sales YoY (2021-2032) & (Tons) Figure 20. Europe Diabetic Therapeutic Drugs Sales YoY (2021-2032) & (Tons) Figure 21. China Diabetic Therapeutic Drugs Sales YoY (2021-2032) & (Tons) Figure 22. Asia (Excluding China) Diabetic Therapeutic Drugs Sales YoY (2021-2032) & (Tons) Figure 23. South America, Middle East and Africa Diabetic Therapeutic Drugs Sales YoY (2021-2032) & (Tons) Figure 24. Global Diabetic Therapeutic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Diabetic Therapeutic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Diabetic Therapeutic Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Diabetic Therapeutic Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Diabetic Therapeutic Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Diabetic Therapeutic Drugs Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 31. Global Diabetic Therapeutic Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Diabetic Therapeutic Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Diabetic Therapeutic Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Diabetic Therapeutic Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Diabetic Therapeutic Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Diabetic Therapeutic Drugs Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Diabetic Therapeutic Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Diabetic Therapeutic Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Diabetic Therapeutic Drugs Revenue Share by Type (2021-2032) Figure 40. North America Diabetic Therapeutic Drugs Sales Share by Type (2021-2032) Figure 41. North America Diabetic Therapeutic Drugs Revenue Share by Application (2021-2032) Figure 42. North America Diabetic Therapeutic Drugs Sales Share by Application (2021-2032) Figure 43. North America Diabetic Therapeutic Drugs Revenue Share by Country (2021-2032) Figure 44. North America Diabetic Therapeutic Drugs Sales Share by Country (2021-2032) Figure 45. Europe Diabetic Therapeutic Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Diabetic Therapeutic Drugs Sales Share by Type (2021-2032) Figure 47. Europe Diabetic Therapeutic Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Diabetic Therapeutic Drugs Sales Share by Application (2021-2032) Figure 49. Europe Diabetic Therapeutic Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Diabetic Therapeutic Drugs Sales Share by Country (2021-2032) Figure 51. China Diabetic Therapeutic Drugs Revenue Share by Type (2021-2032) Figure 52. China Diabetic Therapeutic Drugs Sales Share by Type (2021-2032) Figure 53. China Diabetic Therapeutic Drugs Revenue Share by Application (2021-2032) Figure 54. China Diabetic Therapeutic Drugs Sales Share by Application (2021-2032) Figure 55. Asia Diabetic Therapeutic Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Diabetic Therapeutic Drugs Sales Share by Type (2021-2032) Figure 57. Asia Diabetic Therapeutic Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Diabetic Therapeutic Drugs Sales Share by Application (2021-2032) Figure 59. Asia Diabetic Therapeutic Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Diabetic Therapeutic Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Diabetic Therapeutic Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Diabetic Therapeutic Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Diabetic Therapeutic Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Diabetic Therapeutic Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Diabetic Therapeutic Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Diabetic Therapeutic Drugs Sales Share by Country (2021-2032) Figure 67. Diabetic Therapeutic Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Diabetic Therapeutic Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Therapies
  • Non-Insulin Therapies
Applications
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
Companies covered
  • Arbutus Biopharma
  • AstraZeneca
  • Belrose Pharma
  • Dong-A ST
  • Eisai
  • F. Hoffmann-La Roche
  • Mitsubishi Tanabe Pharma
  • Novo Nordisk
  • Perle Biosciences
  • Sun Pharma
  • Pfizer
  • Eli Lilly
  • Merck
  • Novartis
  • Sanofi
  • Takeda Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Diabetic Therapeutic Drugs Market by Type
  3. 1.2.1 Global Diabetic Therapeutic Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Insulin Therapies
  5. 1.2.3 Non-Insulin Therapies
  6. 1.3 Diabetic Therapeutic Drugs Market by Application
  7. 1.3.1 Global Diabetic Therapeutic Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Type 1 Diabetes
  9. 1.3.3 Type 2 Diabetes
  10. 1.3.4 Gestational Diabetes
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Diabetic Therapeutic Drugs Market Dynamics
  1. 2.1 Diabetic Therapeutic Drugs Industry Trends
  2. 2.2 Diabetic Therapeutic Drugs Industry Drivers
  3. 2.3 Diabetic Therapeutic Drugs Industry Opportunities and Challenges
  4. 2.4 Diabetic Therapeutic Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Diabetic Therapeutic Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Diabetic Therapeutic Drugs Revenue by Region
  3. 3.2.1 Global Diabetic Therapeutic Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Diabetic Therapeutic Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Diabetic Therapeutic Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Diabetic Therapeutic Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Diabetic Therapeutic Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Diabetic Therapeutic Drugs Sales by Region
  9. 3.4.1 Global Diabetic Therapeutic Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Diabetic Therapeutic Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Diabetic Therapeutic Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Diabetic Therapeutic Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Diabetic Therapeutic Drugs Revenue by Manufacturers
  2. 4.1.1 Global Diabetic Therapeutic Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Diabetic Therapeutic Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Diabetic Therapeutic Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Diabetic Therapeutic Drugs Sales by Manufacturers
  6. 4.2.1 Global Diabetic Therapeutic Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Diabetic Therapeutic Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Diabetic Therapeutic Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Diabetic Therapeutic Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Diabetic Therapeutic Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Diabetic Therapeutic Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Diabetic Therapeutic Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Diabetic Therapeutic Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Diabetic Therapeutic Drugs Market CR5 and HHI
  16. 4.8.2 2025 Diabetic Therapeutic Drugs Tier 1, Tier 2, and Tier 3
5 Diabetic Therapeutic Drugs Market by Type
  1. 5.1 Global Diabetic Therapeutic Drugs Revenue by Type
  2. 5.1.1 Global Diabetic Therapeutic Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Diabetic Therapeutic Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Diabetic Therapeutic Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Diabetic Therapeutic Drugs Sales by Type
  6. 5.2.1 Global Diabetic Therapeutic Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diabetic Therapeutic Drugs Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Diabetic Therapeutic Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Diabetic Therapeutic Drugs Price by Type
6 Diabetic Therapeutic Drugs Market by Application
  1. 6.1 Global Diabetic Therapeutic Drugs Revenue by Application
  2. 6.1.1 Global Diabetic Therapeutic Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Diabetic Therapeutic Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Diabetic Therapeutic Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Diabetic Therapeutic Drugs Sales by Application
  6. 6.2.1 Global Diabetic Therapeutic Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Diabetic Therapeutic Drugs Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Diabetic Therapeutic Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Diabetic Therapeutic Drugs Price by Application
7 Company Profiles
  1. 7.1 Arbutus Biopharma
  2. 7.1.1 Arbutus Biopharma Company Information
  3. 7.1.2 Arbutus Biopharma Business Overview
  4. 7.1.3 Arbutus Biopharma Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Arbutus Biopharma Diabetic Therapeutic Drugs Product Portfolio
  6. 7.1.5 Arbutus Biopharma Recent Developments
  7. 7.2 AstraZeneca
  8. 7.2.1 AstraZeneca Company Information
  9. 7.2.2 AstraZeneca Business Overview
  10. 7.2.3 AstraZeneca Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Diabetic Therapeutic Drugs Product Portfolio
  12. 7.2.5 AstraZeneca Recent Developments
  13. 7.3 Belrose Pharma
  14. 7.3.1 Belrose Pharma Company Information
  15. 7.3.2 Belrose Pharma Business Overview
  16. 7.3.3 Belrose Pharma Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Belrose Pharma Diabetic Therapeutic Drugs Product Portfolio
  18. 7.3.5 Belrose Pharma Recent Developments
  19. 7.4 Dong-A ST
  20. 7.4.1 Dong-A ST Company Information
  21. 7.4.2 Dong-A ST Business Overview
  22. 7.4.3 Dong-A ST Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Dong-A ST Diabetic Therapeutic Drugs Product Portfolio
  24. 7.4.5 Dong-A ST Recent Developments
  25. 7.5 Eisai
  26. 7.5.1 Eisai Company Information
  27. 7.5.2 Eisai Business Overview
  28. 7.5.3 Eisai Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Eisai Diabetic Therapeutic Drugs Product Portfolio
  30. 7.5.5 Eisai Recent Developments
  31. 7.6 F. Hoffmann-La Roche
  32. 7.6.1 F. Hoffmann-La Roche Company Information
  33. 7.6.2 F. Hoffmann-La Roche Business Overview
  34. 7.6.3 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Product Portfolio
  36. 7.6.5 F. Hoffmann-La Roche Recent Developments
  37. 7.7 Mitsubishi Tanabe Pharma
  38. 7.7.1 Mitsubishi Tanabe Pharma Company Information
  39. 7.7.2 Mitsubishi Tanabe Pharma Business Overview
  40. 7.7.3 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Mitsubishi Tanabe Pharma Diabetic Therapeutic Drugs Product Portfolio
  42. 7.7.5 Mitsubishi Tanabe Pharma Recent Developments
  43. 7.8 Novo Nordisk
  44. 7.8.1 Novo Nordisk Company Information
  45. 7.8.2 Novo Nordisk Business Overview
  46. 7.8.3 Novo Nordisk Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novo Nordisk Diabetic Therapeutic Drugs Product Portfolio
  48. 7.8.5 Novo Nordisk Recent Developments
  49. 7.9 Perle Biosciences
  50. 7.9.1 Perle Biosciences Company Information
  51. 7.9.2 Perle Biosciences Business Overview
  52. 7.9.3 Perle Biosciences Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Perle Biosciences Diabetic Therapeutic Drugs Product Portfolio
  54. 7.9.5 Perle Biosciences Recent Developments
  55. 7.10 Sun Pharma
  56. 7.10.1 Sun Pharma Company Information
  57. 7.10.2 Sun Pharma Business Overview
  58. 7.10.3 Sun Pharma Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Sun Pharma Diabetic Therapeutic Drugs Product Portfolio
  60. 7.10.5 Sun Pharma Recent Developments
  61. 7.11 Pfizer
  62. 7.11.1 Pfizer Company Information
  63. 7.11.2 Pfizer Business Overview
  64. 7.11.3 Pfizer Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Pfizer Diabetic Therapeutic Drugs Product Portfolio
  66. 7.11.5 Pfizer Recent Developments
  67. 7.12 Eli Lilly
  68. 7.12.1 Eli Lilly Company Information
  69. 7.12.2 Eli Lilly Business Overview
  70. 7.12.3 Eli Lilly Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Eli Lilly Diabetic Therapeutic Drugs Product Portfolio
  72. 7.12.5 Eli Lilly Recent Developments
  73. 7.13 Merck
  74. 7.13.1 Merck Company Information
  75. 7.13.2 Merck Business Overview
  76. 7.13.3 Merck Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Merck Diabetic Therapeutic Drugs Product Portfolio
  78. 7.13.5 Merck Recent Developments
  79. 7.14 Novartis
  80. 7.14.1 Novartis Company Information
  81. 7.14.2 Novartis Business Overview
  82. 7.14.3 Novartis Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Novartis Diabetic Therapeutic Drugs Product Portfolio
  84. 7.14.5 Novartis Recent Developments
  85. 7.15 Sanofi
  86. 7.15.1 Sanofi Company Information
  87. 7.15.2 Sanofi Business Overview
  88. 7.15.3 Sanofi Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sanofi Diabetic Therapeutic Drugs Product Portfolio
  90. 7.15.5 Sanofi Recent Developments
  91. 7.16 Takeda Pharmaceuticals
  92. 7.16.1 Takeda Pharmaceuticals Company Information
  93. 7.16.2 Takeda Pharmaceuticals Business Overview
  94. 7.16.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Product Portfolio
  96. 7.16.5 Takeda Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Diabetic Therapeutic Drugs Market Size by Type
  2. 8.1.1 North America Diabetic Therapeutic Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Diabetic Therapeutic Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Diabetic Therapeutic Drugs Price by Type (2021-2032)
  5. 8.2 North America Diabetic Therapeutic Drugs Market Size by Application
  6. 8.2.1 North America Diabetic Therapeutic Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Diabetic Therapeutic Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Diabetic Therapeutic Drugs Price by Application (2021-2032)
  9. 8.3 North America Diabetic Therapeutic Drugs Market Size by Country
  10. 8.3.1 North America Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Diabetic Therapeutic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Diabetic Therapeutic Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Diabetic Therapeutic Drugs Market Size by Type
  2. 9.1.1 Europe Diabetic Therapeutic Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Diabetic Therapeutic Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Diabetic Therapeutic Drugs Price by Type (2021-2032)
  5. 9.2 Europe Diabetic Therapeutic Drugs Market Size by Application
  6. 9.2.1 Europe Diabetic Therapeutic Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Diabetic Therapeutic Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Diabetic Therapeutic Drugs Price by Application (2021-2032)
  9. 9.3 Europe Diabetic Therapeutic Drugs Market Size by Country
  10. 9.3.1 Europe Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Diabetic Therapeutic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Diabetic Therapeutic Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Diabetic Therapeutic Drugs Market Size by Type
  2. 10.1.1 China Diabetic Therapeutic Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Diabetic Therapeutic Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Diabetic Therapeutic Drugs Price by Type (2021-2032)
  5. 10.2 China Diabetic Therapeutic Drugs Market Size by Application
  6. 10.2.1 China Diabetic Therapeutic Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Diabetic Therapeutic Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Diabetic Therapeutic Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Diabetic Therapeutic Drugs Market Size by Type
  2. 11.1.1 Asia Diabetic Therapeutic Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Diabetic Therapeutic Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Diabetic Therapeutic Drugs Price by Type (2021-2032)
  5. 11.2 Asia Diabetic Therapeutic Drugs Market Size by Application
  6. 11.2.1 Asia Diabetic Therapeutic Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Diabetic Therapeutic Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Diabetic Therapeutic Drugs Price by Application (2021-2032)
  9. 11.3 Asia Diabetic Therapeutic Drugs Market Size by Country
  10. 11.3.1 Asia Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Diabetic Therapeutic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Diabetic Therapeutic Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Diabetic Therapeutic Drugs Market Size by Type
  2. 12.1.1 SAMEA Diabetic Therapeutic Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Diabetic Therapeutic Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Diabetic Therapeutic Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Diabetic Therapeutic Drugs Market Size by Application
  6. 12.2.1 SAMEA Diabetic Therapeutic Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Diabetic Therapeutic Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Diabetic Therapeutic Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Diabetic Therapeutic Drugs Market Size by Country
  10. 12.3.1 SAMEA Diabetic Therapeutic Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Diabetic Therapeutic Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Diabetic Therapeutic Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Diabetic Therapeutic Drugs Value Chain Analysis
  2. 13.1.1 Diabetic Therapeutic Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Diabetic Therapeutic Drugs Production Mode & Process
  6. 13.2 Diabetic Therapeutic Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Diabetic Therapeutic Drugs Distributors
  9. 13.2.3 Diabetic Therapeutic Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst